MétaCan
Menu
Back to cohort
Record W4416021853 · doi:10.1016/s2214-109x(25)00415-2

Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi

2025· article· en· W4416021853 on OpenAlexaff
Latif Ndeketa, Valérie Haine, Muriel Debois, Kwaku Poku Asante, Prince Darko Agyapong, Seyram Kaali, Raghavendra Devadiga, Samuel Harrison, Owusu Boahen, Neil French, Kingsley Kayan, Bernhards Ogutu, Elisha Adeniji, Simon Kariuki, Seth Owusu‐Agyei, Fredrick Olewe, Tikhala Makhaza Jere, Kenneth Maleta, Donnie Mategula, Phylis Mzanga, Vincent Katunga-Phiri, John Orimbo, Nana Akosua Ansah, Mattéa Orsini, John Michael Ong’echa, Abraham Oduro, Peter Sifuna, Daniel Azongo, Walter Otieno, Oscar Bangre, Michael B. Kaburise, Lucy O Ababio, Janet Oyieko, Valentine Sing’oei, Stellah Kevyne Amoit, Wongani Nyangulu, Lode Schuerman, Denis Awuni, Benard Ochieng, Irene Onyango, Patricia Odera-Ojwang, Esther Achieng Oguk, Yolanda Guerra Mendoza, Reuben Yego Cherop, George Odhiambo Okoth, Cristina Cravcenco, Raphael Chipatala, François Roman, Martina Oneko, Miloje Savic, Oscar Agyei, Joseph A Ana-aro, Cynthia Aton, Yvonne Berko, Dennis K Bii, Miriam Chomba, David Dosoo, Clifford Kwarteng Kyeremateng, Jane Masinde, Paul Njika, James Nyagechanga, A.D. Odila, Dan Omollo, Samuel Osei-Owusu, Kephas Otieno, Daniel Ouko, Emmanuel Yirenkyi

Bibliographic record

VenueThe Lancet Global Health · 2025
Typearticle
Languageen
FieldMedicine
TopicMalaria Research and Control
Canadian institutionsRegional Municipality of Waterloo
FundersKenya Medical Research InstituteGlaxoSmithKline
KeywordsInterim analysisInterimMalariaMalaria vaccinePhase (matter)MEDLINE

Abstract

fetched live from OpenAlex

Background RTS,S/AS01 E was first introduced within the Malaria Vaccine Implementation Programme in selected areas in Ghana, Kenya, and Malawi. A series of post-introduction observational studies were initiated in these areas to assess RTS,S/AS01 E safety and effectiveness in real-world settings. Here, we report the results of the interim analysis of the EPI-MAL-003 study secondary objectives related to vaccine effectiveness. Methods EPI-MAL-003 was a phase 4, disease surveillance study with prospective cohort event monitoring. The study was performed in routine medical practice settings at 12 sites (four per country) in Ghana, Kenya, and Malawi. Children younger than 18 months were enrolled in exposed clusters (sites where RTS,S/AS01 E was introduced) and unexposed clusters; data were collected via active surveillance. In an interim analysis, we estimated the effect of vaccination on the incidence of malaria, all-cause hospitalisations, and malaria-related hospitalisations, the prevalence of anaemia among hospitalised children, and mortality over 1 year of follow-up after primary vaccination with three RTS,S/AS01 E doses. These endpoints were analysed in the effectiveness analysis set. The primary endpoints are reported elsewhere, together with secondary safety endpoints. This study is registered with ClinicalTrials.gov, NCT03855995, and is completed. Findings The first child was enrolled on March 21, 2019, and the cutoff date for the current analysis was Nov 2, 2023. 45 000 children were enrolled (22 426 [49·8%] were female and 22 574 [50·25%] were male). 39 463 children were included in the analyses. When comparing vaccinated children from exposed clusters with unvaccinated children from unexposed clusters, country-adjusted incidence rate ratios were 0·70 (95% CI 0·67–0·73; p<0·001) for any malaria, 0·42 (0·30–0·60; p<0·001) for severe malaria, 0·64 (0·56–0·72; p<0·001) for malaria-related hospitalisations, 0·79 (0·74–0·84; p<0·001) for all-cause hospitalisations, and 0·83 (0·64–1·09; p=0·18) for all-cause mortality. The adjusted odds ratio for the prevalence of anaemia among children who were hospitalised (vaccinated children from exposed clusters vs unvaccinated children from unexposed clusters) was 0·81 (95% CI 0·73–0·90; p<0·001). Similar trends were observed in a before–after comparison with unvaccinated children enrolled in the EPI-MAL-002 study conducted before the RTS,S/AS01 E introduction. Interpretation Over 1 year of follow-up after the third vaccine dose, vaccination with RTS,S/AS01 E in real-world settings showed significant reductions in malaria burden. These findings reinforce the continued use of RTS,S/AS01 E vaccination in children as an effective public health measure to reduce malaria-related illness and mortality in endemic regions, and highlight its relevance for future malaria control strategies. Funding GSK.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.036
Threshold uncertainty score0.995

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.002
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.021
GPT teacher head0.390
Teacher spread0.369 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Global HealthSame topicMalaria Research and ControlFrench-language works237,207